hackint0sh/New-Dataset huggingface dataset:
nctId: NCT06271538 id: EP-USM-122023-001 briefTitle: Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome overallStatus: NOT_YET_RECRUITING date: 2024-05-31 date: 2024-11-30 date: 2025-03-30 date: 2024-02-21 date: 2024-04-26 name: EP Plus Group Sdn Bhd class: INDUSTRY briefSummary: The objective of this randomized, double-blind, placebo-controlled study is to evaluate the effectiveness of Skal Pro in alleviating symptoms, enhancing stool consistency, improving quality of life, and addressing psychological distress in individuals diagnosed with irritable bowel syndrome (IBS), as compared to those who receive no intervention. conditions: Irritable Bowel Syndrome conditions: Gastrointestinal Diseases conditions: Colonic Diseases, Functional conditions: Intestinal Disease conditions: Digestive System Disease conditions: Pathologic Processes conditions: Colonic Disease conditions: Disease studyType: INTERVENTIONAL phases: PHASE4 allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: DOUBLE whoMasked: PARTICIPANT whoMasked: INVESTIGATOR count: 60 type: ESTIMATED name: Skal Pro name: Placebo measure: Improving the severity of symptoms in individuals with IBS, assessed by IBS Symptom Severity Scale (IBSSSS) measure: Change in stool consistency (Bristol Stool Scale), assessed by daily stool diary measure: Change in stool frequency and satisfaction after passing stool, assessed by daily stool diary measure: Change in abdominal bloating, assessed by Bloating Severity Questionnaire (BSQ) measure: Improvement in Quality of Life, assessed by EQ-5D-5L Questionnaire measure: Change in Visceral Sensitivity Index measure: Assessment of psychological dysfunction suing Catastrophizing Questionnaire sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Hospital Universiti Sains Malaysia city: Kubang Kerian state: Kelantan zip: 16150 country: Malaysia name: Yeong Yeh Lee, MD, PhD role: CONTACT phone: +6097676846 phoneExt: 6845 email: yylee@usm.my name: Yeong Yeh Lee, MD, PhD role: PRINCIPAL_INVESTIGATOR name: Thai Hau Koo, MD role: SUB_INVESTIGATOR lat: 6.09123 lon: 102.27938 hasResults: False
nctId: NCT06271525 id: P.T.REC/012/002532 briefTitle: Effect of Cupping Therapy on Nitric Oxide Level in Patients With Cervical Spondylosis acronym: CT overallStatus: NOT_YET_RECRUITING date: 2024-02-20 date: 2024-05-20 date: 2024-05-20 date: 2024-02-21 date: 2024-02-21 name: Shady Abdelsattar Refaat class: OTHER briefSummary: this study will be conducted to investigate the effect of cupping therapy on the nitric oxide level in patients with cervical spondylosis conditions: Cervical Spondylosis studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP interventionModelDescription: cupping therapy primaryPurpose: TREATMENT masking: NONE count: 60 type: ESTIMATED name: cupping therapy measure: the nitric oxide level measure: cervical range of motion measure: pain intensity sex: ALL minimumAge: 24 Years maximumAge: 65 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06271512 id: REG-501 briefTitle: A Study of Participants With β-Thalassemia Treated With Betibeglogene Autotemcel overallStatus: RECRUITING date: 2024-01-23 date: 2043-12 date: 2043-12 date: 2024-02-21 date: 2024-02-21 name: bluebird bio class: INDUSTRY name: Center for International Blood and Marrow Transplant Research briefSummary: The main aim of this study is to collect real-world longitudinal data on participants with β-thalassemia treated with betibeglogene autotemcel (beti-cel) in the post marketing setting. To assess the long-term safety, including the risk of newly diagnosed malignancies, after treatment with beti-cel and evaluate the long-term effectiveness of treatment with beti-cel. conditions: Beta-Thalassemia studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 150 type: ESTIMATED name: No Intervention measure: Number of Participants who Experience Each Individual Adverse Events of Interest (AEIs) measure: Number of Participants with Serious Adverse Events (SAEs) measure: Number of Participants with beti-cel related AEs measure: Event-Free Survival measure: Percentage of Participants Achieving Transfusion Independence sex: ALL stdAges: CHILD stdAges: ADULT stdAges: OLDER_ADULT facility: UCSF Benioff Children's Hospitals status: RECRUITING city: Oakland state: California zip: 94609 country: United States lat: 37.80437 lon: -122.2708 hasResults: False
nctId: NCT06271499 id: AnkaraU-Smart-cannulation briefTitle: The Effect of Using Smart Glasses Integrated Ultrasonography on Radial Artery Catheterization overallStatus: COMPLETED date: 2022-08-01 date: 2022-12-28 date: 2023-02-14 date: 2024-02-21 date: 2024-02-21 name: Ankara University class: OTHER name: Ayşegül Güven name: Bengi Safak name: Ahmet Onat Bermede briefSummary: The use of Ultrasonography (USG) in arterial catheterization, in which the comfort of the practitioner and hand-eye coordination become very important, is frequently needed by anesthesiologists in their daily practice. The aim of this study is to evaluate the success rate and anesthesiologist's satisfaction between two practitioners with different levels of experience in radial artery catheterization with smart glasses USG. conditions: Catheterization conditions: Cannulation studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: SUPPORTIVE_CARE masking: NONE count: 120 type: ACTUAL name: Radial artery catheterization with USG name: Radial artery catheterization with smart glasses integrated UGG measure: The success rate measure: The anesthesiologist's satisfaction measure: The cannulation time measure: Complications sex: ALL minimumAge: 18 Years maximumAge: 90 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Ankara University Medical Faculty city: Ankara country: Turkey lat: 39.91987 lon: 32.85427 hasResults: False
nctId: NCT06271486 id: RC. 40.5.2023 briefTitle: Pregabalin in Treatment of Postdural Puncture Headache overallStatus: RECRUITING date: 2024-02-28 date: 2024-08-15 date: 2024-08-15 date: 2024-02-21 date: 2024-03-15 name: Al-Azhar University class: OTHER name: Benha University briefSummary: Lumbar puncture (LP), often known as a "spinal tap," is a standard medical technique pioneered in the late 1900s by Heinrich Quincke. It involves the retrieval and analysis of cerebrospinal fluid (CSF) from the spinal cord, serving as the benchmark for diagnosing conditions like subarachnoid hemorrhage, meningitis, and specific neurological conditions. Pregabalin, an anticonvulsant medicine that blocks calcium entry, is used to treat a variety of diseases. It has been used to relieve pain in a variety of patient groups, including those with chronic pain, epilepsy, and anxiety disorders conditions: Postdural Puncture Headache studyType: INTERVENTIONAL phases: PHASE3 allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: SINGLE whoMasked: OUTCOMES_ASSESSOR count: 75 type: ESTIMATED name: Pregabalin 75mg name: An epidural blood patch (EBP) name: conservative treatment. measure: the incidence of complete relief measure: The intensity of the headache sex: ALL minimumAge: 21 Years maximumAge: 65 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Neveen Kohaf status: RECRUITING city: Tanta zip: 11865 country: Egypt name: Neveen Kohaf role: CONTACT phone: +201060383012 email: nevenabdo@azhar.edu.eg name: Nahed F. Abo-Elmatey, M.D role: PRINCIPAL_INVESTIGATOR name: Hany Bauiomy, M.D role: PRINCIPAL_INVESTIGATOR name: Ahmed M. Abosakaya, M.D role: PRINCIPAL_INVESTIGATOR lat: 30.78847 lon: 31.00192 hasResults: False
nctId: NCT06271473 id: AinShamsU3 briefTitle: Effect of PPV+ILM Peeling +/- Subretinal Injection of Ringer Lactate in Management of Nontractional Refractory DME overallStatus: RECRUITING date: 2023-08-30 date: 2024-12-30 date: 2025-06-30 date: 2024-02-21 date: 2024-02-21 name: Ain Shams University class: OTHER briefSummary: To evaluate the efficacy and safety of combined pars plana vitrectomy and planned foveal detachment through subretinal injection of ringer's solution in patients with non-tractional refractory diabetic macular edema. conditions: Efficacy conditions: Safety studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: 20 eyes of 20 patients will be divided randomly into 2 groups:
* Group (B): 10 eyes subjecting to vitrectomy + ILM peeling + planned foveal detachment via subretinal injection of ringer's solution. primaryPurpose: TREATMENT masking: NONE count: 20 type: ESTIMATED name: vitrectomy + ILM peeling +/- planned foveal detachment via subretinal injection of ringer's solution. measure: change in CMT by OCT at final visit measure: change in BCVA at final visit measure: any surgical complication or recurrence of DME sex: ALL minimumAge: 40 Years maximumAge: 80 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Ain Shams university status: ACTIVE_NOT_RECRUITING city: Cairo country: Egypt lat: 30.06263 lon: 31.24967 facility: Ain Shams university status: RECRUITING city: Cairo country: Egypt name: Azza MA Said, MD role: CONTACT phone: +201006228992 email: dr_azza_22@hotmail.com name: David G Samuel, Msc role: CONTACT phone: +201064442469 email: david.samuel.ophth@gmail.com lat: 30.06263 lon: 31.24967 hasResults: False
nctId: NCT06271460 id: 2023-21-728 briefTitle: Disability in Patients With Non-specific Chronic Low Back Pain overallStatus: RECRUITING date: 2024-03-04 date: 2024-08 date: 2024-10 date: 2024-02-21 date: 2024-03-08 name: Acibadem University class: OTHER briefSummary: To investigate the reliability and sensitivity of the Turkish versions of the Roland-Morris Disability Questionnaire, The Quebec Back Pain Disability Scale, and the Oswestry Disability Index in patients with chronic non-specific low back pain and to increase confidence in their use in clinical practice and research by determining the most appropriate minimal clinically significant difference values for this patient population. conditions: Chronic Nonspecific Low Back Pain studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 100 type: ESTIMATED name: Traditional physiotherapy measure: Visual Analog Scale measure: The Roland-Morris Disability Questionnaire measure: The Quebec Back Pain Disability Scale measure: The Oswestry Disability Index measure: The Perceived Global Impact sex: ALL minimumAge: 18 Years maximumAge: 65 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Acıbadem Health Group status: RECRUITING city: Istanbul state: None Selected zip: 34752 country: Turkey name: Elif E Safran, asst. prof. role: CONTACT phone: 500 4047 phoneExt: 216 email: elif.bayraktar@acibadem.edu.tr name: Irmak Çavuşoğlu, asst. prof. role: CONTACT phone: 500 4184 phoneExt: 216 email: irmak.cavusoglu@acibadem.edu.tr name: Elif E Safran, asst. prof. role: PRINCIPAL_INVESTIGATOR name: Irmak Çavuşoğlu, asst. prof. role: PRINCIPAL_INVESTIGATOR name: Nuray Alaca, assoc. prof. role: SUB_INVESTIGATOR lat: 41.01384 lon: 28.94966 hasResults: False
nctId: NCT06271447 id: 2023-21-705 briefTitle: Answerability and Minimal Clinical Significance of the Pain Questionnaires overallStatus: RECRUITING date: 2024-03-04 date: 2024-06 date: 2024-08 date: 2024-02-21 date: 2024-03-08 name: Acibadem University class: OTHER briefSummary: To investigate the reliability and sensitivity of the Turkish versions of the Fear-Avoidance Beliefs Questionnaire, Tampa Scale for Kinesiophobia, and The Pain Catastrophizing Scale in patients with chronic non-specific low back pain undergoing multidisciplinary rehabilitation. conditions: Chronic Low-back Pain studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 100 type: ESTIMATED name: Traditional therapy measure: Visual Analog Scale measure: Fear-Avoidance Beliefs Questionnaire measure: Tampa Scale for Kinesiophobia measure: The Pain Catastrophizing Scale measure: The Perceived Global Impact sex: ALL minimumAge: 18 Years maximumAge: 65 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Elif Esma Safran status: RECRUITING city: Istanbul state: None Selected zip: 34752 country: Turkey name: Elif E Safran, asst. prof. role: CONTACT phone: 500 4047 phoneExt: 216 email: elif.bayraktar@acibadem.edu.tr name: Nuray N Alaca, assoc. prof. role: CONTACT phone: 500 4184 phoneExt: Safran email: elifesmabayraktar@hotmail.com name: Elif E Safran, asst. prof. role: PRINCIPAL_INVESTIGATOR name: Irmak I Çavuşoğlu, asst. prof. role: PRINCIPAL_INVESTIGATOR name: Nuray N Alaca, assoc. prof. role: SUB_INVESTIGATOR lat: 41.01384 lon: 28.94966 hasResults: False
nctId: NCT06271434 id: Olej z kryla/jelita briefTitle: Effects of Krill Oil on Intestinal Integrity Markers in Elite Rowers. overallStatus: NOT_YET_RECRUITING date: 2024-03-23 date: 2024-06-24 date: 2024-06-24 date: 2024-02-21 date: 2024-03-18 name: Poznan University of Physical Education class: OTHER briefSummary: The study aims to check the influence of krill oil on markers of intestinal injury and intoxication.
B. control (n = 15) receiving placebo. The supplementation period will be six weeks. primaryPurpose: BASIC_SCIENCE masking: TRIPLE maskingDescription: Triple whoMasked: PARTICIPANT whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 30 type: ESTIMATED name: THYROX (Atlantic krill oil name: Placebo measure: I-FABP (intestinal fatty acid binding protein) measure: CLDN-3 measure: LBP (lipopolysaccharide binding protein) measure: Catechyloamines, cortisol measure: CD14 measure: Food intake sex: ALL minimumAge: 18 Years maximumAge: 24 Years stdAges: ADULT hasResults: False
nctId: NCT06271421 id: 01/24 briefTitle: NanoTherm In Adjuvant Therapy of Glioblastoma Multiforme acronym: ANCHIALE overallStatus: RECRUITING date: 2024-01-01 date: 2027-02-01 date: 2027-09-01 date: 2024-02-21 date: 2024-02-26 name: Poznan University of Medical Sciences class: OTHER name: MagForce USA briefSummary: Glioblastoma multiforme (GBM), the most common and malignant primary brain tumor in adults is classified as a World Health Organisation (WHO) grade 4. Surgical removal of the tumor is the primary method of treatment. Unfortunately, because GBM is a disease of the entire brain, total resection is not possible. Therefore, the use of radiotherapy and/or chemotherapy is considered as Stupp protocol. Patients with recurrent GBM will be included in the ANCHIALE study.
2. are included for standard Stupp protocol (surgery/chemo-radiotherapy) (group B) primaryPurpose: TREATMENT masking: NONE maskingDescription: ANCHIALE is open-label study count: 100 type: ESTIMATED name: NanoTherm therapy name: Glioma Resection name: radiotherapy according to Stupp protocol name: chemotherapy according to Stupp protocol measure: Survival following the surgery [units months 1-24] measure: Progression free survival [units months 1-24] measure: Response Assessment in Neuro-oncology [1 - complete response; 4 -progressive disease] measure: EuroQuality of Life 5-dimensions-5 levels scale (EQ-5D-5L) [arbitraty units 0- worst ; 100 - best] measure: Neurologic Assessment in Neuro-Oncology (NanoScale 2) [0-best; 23-worst] measure: modified Rankin scale [0-best; 6-worst] measure: Barthel index [range 0-100; 0-best, 100-worst] sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: University Hospital status: RECRUITING city: Poznań zip: 60-355 country: Poland name: Slawomir Michalak, Prof. role: CONTACT phone: +4861 8691 535 email: swami@ump.edu.pl name: Jakub Moskal, MD, PhD role: CONTACT phone: +4861 8691 422 email: jakub.moskal@usk.poznan.pl lat: 52.40692 lon: 16.92993 hasResults: False
nctId: NCT06271408 id: POL-Xe-005 briefTitle: Comparison of Bronchodilator Response From Three Different Aerosol Delivery Methods in Patients With COPD Using Hyperpolarized Xe 129 MRI Ventilation Imaging overallStatus: RECRUITING date: 2024-02 date: 2024-04 date: 2024-04 date: 2024-02-21 date: 2024-02-21 name: Polarean, Inc. class: INDUSTRY name: Aerogen briefSummary: The goal of this clinical trial is to compare responses to bronchodilator treatment delivered by three different aerosol delivery methods in patients with chronic obstructive pulmonary disease (COPD). The main question it aims to answer is whether there are differences in lung ventilation following treatment with each of the three methods as measured using hyperpolarized Xe 129 with MRI.
Researchers will compare the different lung images taken after each treatment to see if there are differences in the distribution of air in the lungs (known as ventilation). conditions: Chronic Obstructive Pulmonary Disease studyType: INTERVENTIONAL phases: PHASE1 allocation: NON_RANDOMIZED interventionModel: CROSSOVER primaryPurpose: TREATMENT masking: SINGLE whoMasked: OUTCOMES_ASSESSOR count: 6 type: ESTIMATED name: Albuterol Sulfate, 2.5 Mg/3 mL (0.083%) Inhalation Solution name: Vibrating Mesh Nebulizer name: Metered Dose Inhaler name: Jet Nebulizer measure: Ventilation Defect Percent measure: Distribution of ventilated space measure: Membrane uptake of Xe 129 measure: Red blood cell Xe 129 transfer sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: University of Virginia Sheridan Snyder Translational Fontaine Research Unit status: RECRUITING city: Charlottesville state: Virginia zip: 22947 country: United States name: Roselove Roselove Nunoo-Asare role: CONTACT phone: 434-243-6074 email: rnn3b@virginia.edu lat: 38.02931 lon: -78.47668 hasResults: False
nctId: NCT06271395 id: Chaoshengqiunang briefTitle: Ultrasound-guided Botulinum Toxin Injection on Cricopharyngeal Muscle Dysfunction overallStatus: RECRUITING date: 2024-02-28 date: 2024-10 date: 2024-10 date: 2024-02-21 date: 2024-03-07 name: Zeng Changhao class: OTHER briefSummary: Ultrasound-guided injection is a visual, convenient, and radiation-free technique that allows real-time observation of the needle insertion process and drug injection location. The combination with a balloon for fixation further enhances the precision of the injection. In this study, we employed ultrasound-guided injection combined with balloon localization for cricopharyngeal muscle botulinum toxin injection treatment and conducted clinical observations. conditions: Cricopharyngeal Achalasia studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: TREATMENT masking: NONE count: 30 type: ESTIMATED name: Injectable Type A Botulinum Toxin measure: functional oral intake scale measure: Penetration-Aspiration Scale measure: The Fiberoptic Endoscopic Dysphagia Severity Scale measure: Murray secretion scale sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Xinzhu Rehabilitation Hospital status: RECRUITING city: Xinzhu country: Taiwan name: Haim Liu role: CONTACT lat: 22.46205 lon: 120.47335 hasResults: False
nctId: NCT06271382 id: AIBU-SBF-SA-05 briefTitle: The Effect Of Acupressure and Foot Exercise on Ankle Brachial Index in Individuals With Type 2 Diabetes overallStatus: NOT_YET_RECRUITING date: 2024-02-15 date: 2025-02-15 date: 2025-02-15 date: 2024-02-21 date: 2024-02-21 name: Abant Izzet Baysal University class: OTHER briefSummary: This study was planned with a randomized controlled experimental design to examine the effects of acupressure and ankle exercises on ankle brachial index in individuals with Type 2 diabetes. conditions: Diabetes Mellitus, Type 2 studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: SUPPORTIVE_CARE masking: SINGLE whoMasked: OUTCOMES_ASSESSOR count: 66 type: ESTIMATED name: Acupressure Group name: Sham Acupressure Group name: Foot Ankle Exercise Group measure: Ankle Brachial Index sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06271369 id: CCTL019CUS13 briefTitle: Real-World HRU and Costs in DLBCL Pts With Tisa-cel and Axi-cel, a Medicare Study. overallStatus: COMPLETED date: 2022-08-11 date: 2023-02-15 date: 2023-02-15 date: 2024-02-21 date: 2024-02-21 name: Novartis Pharmaceuticals class: INDUSTRY briefSummary: This was a retrospective non-interventional cohort study design using the Centers for Medicare and Medicaid Services (CMS) 100% Medicare data (2015Q1-2020Q4).
Eligible adult patients with r/r DLBCL who were treated with CAR-T therapy were identified from the CMS 100% Medicare data. Patients who received chimeric antigen receptor modified T cell (CAR-T) therapy were further classified into tisa-cel and axi-cel cohorts based on the type of CAR-T treatment received. The index date was defined as the date of tisa-cel or axi-cel therapy administration. Baseline period was defined as three months prior to the index date. Study period was defined from the index date to the end of health plan coverage based on insurance enrollment file or death, whichever occurred earlier. conditions: Diffuse Large B-cell Lymphoma studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: RETROSPECTIVE count: 613 type: ACTUAL measure: Number of patients with IP admission measure: Number of IP admissions measure: IP days measure: Number of ICU stays measure: ICU days measure: Number of patients with OP visit measure: Number of OP visits measure: Number of patients with ER visit measure: Number of ER visits measure: Healthcare reimbursement costs measure: Overall survival (OS) measure: Time to next treatment (TTNT) or death sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Novartis city: East Hanover state: New Jersey zip: 07936 country: United States lat: 40.8201 lon: -74.36487 hasResults: False
nctId: NCT06271356 id: STU00220278 briefTitle: Breast Cancer - Navigate - Prospective Cohort overallStatus: NOT_YET_RECRUITING date: 2024-03 date: 2025-03 date: 2025-04 date: 2024-02-21 date: 2024-02-21 name: Northwestern University class: OTHER name: The Chrysalis Initiative briefSummary: The Chrysalis Initiative (TCI) has with its technology partner Eversana/Intouch developed the BC-Navigate website/application to help guide women through care delivery during breast cancer treatment.
Therefore, the purpose of this study is to apply TCI's patient navigation-and-coaching program and its website/mobile app (Breast Cancer-Navigate) platform to improve timely initiation to patient adjuvant treatment among WOC breast cancer patients and evaluate the feasibility and preliminary efficacy of this approach. conditions: Breast Cancer conditions: Quality of Life conditions: Chemotherapy studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: SUPPORTIVE_CARE masking: NONE count: 150 type: ESTIMATED name: BC-Navigate measure: Demand of BC-Navi: Recruitment Rate measure: Demand of BC-Navi: Rentention Rate measure: Acceptability of BC-Navi measure: Preliminary Efficacy: Chemotherapy Initiation sex: FEMALE minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Northwestern University city: Chicago state: Illinois zip: 60611 country: United States name: Diana Buitrago role: CONTACT phone: 312-503-2866 email: diana.buitrago@northwestern.edu lat: 41.85003 lon: -87.65005 hasResults: False
nctId: NCT06271343 id: RC23_0394 briefTitle: Kidney Graft Tolerance KTOL acronym: KTOL overallStatus: RECRUITING date: 2024-03-20 date: 2026-03-01 date: 2026-06-01 date: 2024-02-21 date: 2024-03-21 name: Nantes University Hospital class: OTHER name: Institut National de la Santé Et de la Recherche Médicale, France briefSummary: Prospective experimental study using PBMC from a limited number of adult patients (15) treated at Nantes University Hospital for a kidney transplant from a related living donor.